![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 08, 2020 3:08:42 PM
We can assume that phase III trial is pretty close to complete now, so why open up a new trial site unless it is to be used for the NIH trial as well? I could be completely crazy.. but it kind of makes sense.
We are pleased to announce we’ve added MedStar Washington Hospital Center @MedStarWHC to our study sites participating in our Phase 3 study of lenzilumab in patients with COVID-19.
— Humanigen, Inc. (@humanigen) October 8, 2020
Please visit our website to locate a clinical site near you.https://t.co/nDPb48IacU$HGEN
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM